Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.3
-59.53%
20%
—
-88.11%
40%
—
5 Years
Score2.3
Net Growth-59.53%
Net Trend20%
Net Income Consistency—
Rev Growth-88.11%
Rev Trend40%
Revenue Consistency—
Milestone Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 15M to $ 1M and net income went from -$ 49M to -$ 63M. Revenue increased in 2 of those 5 years; net income in 1.
Milestone Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.13 | — |
1 Year2025-08-12 | $ 1.66 | -32.23% |
5 Years2021-08-12 | $ 5.35 | -78.97% |
All Time2019-05-09 | $ 15.37 | -92.68% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2019-05-09 |
|---|---|---|---|---|
| Price | $ 1.13 | $ 1.66 | $ 5.35 | $ 15.37 |
| Return | — | -32.23% | -78.97% | -92.68% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 68M | $ 184M |
| 2025 | $ 1M | -$ 63M | $ 105M |
| 2024 | $ 0.00 | -$ 41M | $ 69M |
| 2023 | $ 1M | -$ 59M | $ 66M |
| 2022 | $ 5M | -$ 57M | $ 64M |
| 2021 | $ 15M | -$ 42M | $ 114M |
| 2020 | $ 15M | -$ 49M | $ 142M |
| IPO2019 | $ 0.00 | -$ 55M | $ 119M |
Explore beyond MIST
You're looking at Milestone Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
